Introduction Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality.
There has been little change in PE mortality rates over the past two decades making this an …

Objectives: The purpose of this study is to assess the efficacy, short-and long-term
cardiovascular and non-cardiovascular mortalities and postoperative morbidities of surgical …

Background Acute pulmonary embolism (PE) is one of the most critical cardiovascular
diseases. PE treatment ranges from anticoagulation, and systemic thrombolysis to surgical …

Massive pulmonary embolism (PE) is the most serious manifestation of venous
thromboembolic disease, leading to inpatient mortality rates as high as 60% from right …

Purpose: Low-risk pulmonary thromboembolism (PTE) outpatient management has been
described recently. The blood neutrophil/lymphocyte ratio (NLR) has been shown to be a …

Massive pulmonary thromboembolism (PTE) has an increased risk of mortality. Thrombolytic
therapy is the accepted treatment. Reteplase, a variant of tissue plasminogen activator, has …

Acute pulmonary embolism (PE) remains a life-threatening condition despite advances in
diagnostic and therapeutic modalities. Treatment modalities include systemic thrombolysis …

Цель исследования-проанализировать современные данные и тенденции в
хирургическом лечении тромбоэмболии легочной артерии (ТЭЛА). Хирургическое …

Objective Presented is a single-case of a novel technique of catheter-directed thrombolysis
via an existing implanted venous-access port for treatment of a right atrial thrombus. Case …

MODERN TRENDS IN THE SURGICAL TREATMENT OF MASSIVE PULMONARY EMBOLISM
(review of literature) | Khubulava | Grekov's Bulletin of Surgery Grekov's Bulletin of Surgery …